Duarte, California
Colorectal cancer clinical trials in Duarte, CA
50 colorectal cancer studies are recruiting participants at sites in Duarte as of November 16, 2026, according to ClinicalTrials.gov. Colorectal Cancer Clinical Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Duarte at a glance
- 50 studies are recruiting at a site in Duarte.
- By phase: Phase 1 (21), Phase 1/2 (4), Phase 2 (8), Phase 2/3 (1), Phase 3 (3), No phase (3), Observational (10). Studies of devices and behavioral approaches have no phase.
- By sponsor: industry (30), university, hospital or other (20).
- Most recent update to one of these records: November 12, 2026.
Studies recruiting in Duarte
Basic details from each study's public record (the 30 most recently updated of 50). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Vividion Therapeutics, Inc.
- Study site
- City of Hope Cancer Center
- Registry record
- NCT06004245 · updated
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- IDEAYA Biosciences
- Study site
- City of Hope Comprehensive Cancer Center
- Registry record
- NCT07503808 · updated
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Hoffmann-La Roche
- Study site
- City of Hope Comprehensive Cancer Center
- Registry record
- NCT04929223 · updated
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Summit Therapeutics
- Registry record
- NCT07228832 · updated
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Pfizer
- Study site
- City of Hope (City of Hope National Medical Center, City of Hope Medical Center)
- Registry record
- NCT07318805 · updated
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
- Phase 2/3
- Ages 18 and older
- All sexes
- Sponsor
- NRG Oncology
- Study site
- City of Hope Comprehensive Cancer Center
- Registry record
- NCT05174169 · updated
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Observational
- Ages 40 and older
- All sexes
- Sponsor
- Adela, Inc
- Study site
- City of Hope
- Registry record
- NCT05366881 · updated
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Bayer
- Study site
- City of Hope - Duarte Cancer Center
- Registry record
- NCT06760819 · updated
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- City of Hope
- Registry record
- NCT07114601 · updated
Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- City of Hope Medical Center
- Study site
- City of Hope Medical Center
- Registry record
- NCT06130826 · updated
LYL273 for Patients With Relapsed or Refractory mCRC
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Lyell Immunopharma, Inc.
- Study site
- City of Hope Comprehensive Cancer Center
- Registry record
- NCT05319314 · updated
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- AbbVie
- Study site
- City of Hope National Medical Center /ID# 270255
- Registry record
- NCT06820463 · updated
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Delcath Systems Inc.
- Study site
- City of Hope
- Registry record
- NCT06607458 · updated
Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- BigHat Biosciences, Inc.
- Study site
- City of Hope Duarte
- Registry record
- NCT07529808 · updated
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- AbbVie
- Study site
- City of Hope National Medical Center /ID# 279449
- Registry record
- NCT07525206 · updated
Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- City of Hope Medical Center
- Study site
- City of Hope Medical Center
- Registry record
- NCT07595874 · updated
A Study to Learn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorectal Cancer That Has a KRAS G12D Mutation
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Bayer
- Study site
- City of Hope - Duarte Cancer Center
- Registry record
- NCT07535112 · updated
A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Dispatch Biotherapeutics
- Study site
- City of Hope
- Registry record
- NCT07544589 · updated
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
- Study site
- City of Hope Comprehensive Cancer Center
- Registry record
- NCT06625775 · updated
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- AstraZeneca
- Registry record
- NCT05877599 · updated
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Phanes Therapeutics
- Study site
- City of Hope (City of Hope National Medical Center, City of Hope Medical Center)
- Registry record
- NCT05482893 · updated
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Aktis Oncology, Inc.
- Study site
- City of Hope
- Registry record
- NCT07020117 · updated
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- EvolveImmune United, Inc
- Study site
- City of Hope
- Registry record
- NCT07217171 · updated
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
- Phase 1
- Ages 12 to 85
- All sexes
- Sponsor
- Inhibrx Biosciences, Inc
- Study site
- City of Hope
- Registry record
- NCT03715933 · updated
Testing the Effects of Exercise on Colorectal Cancer Development After Treatment With Pelvic Radiation Therapy for Prostate Cancer
- No phase
- Ages 40 to 80
- Male participants
- Sponsor
- City of Hope Medical Center
- Study site
- City of Hope Medical Center
- Registry record
- NCT07790718 · updated
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- City of Hope Medical Center
- Study site
- City of Hope Medical Center
- Registry record
- NCT04329494 · updated
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Cartography Biosciences
- Study site
- City of Hope Duarte
- Registry record
- NCT07321106 · updated
Minimal Residual Disease Testing for the Early Detection of Cancer Recurrence in Resectable Stage II-IV Colorectal Cancer Patients
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- City of Hope Medical Center
- Study site
- City of Hope Comprehensive Cancer Center
- Registry record
- NCT07125729 · updated
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Xencor, Inc.
- Study site
- Xencor Investigative Site
- Registry record
- NCT05433142 · updated
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Amgen
- Study site
- City of Hope National Medical Center
- Registry record
- NCT07094113 · updated
Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Duarte, CA on ClinicalTrials.gov.
Ask about studies near Duarte
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in California
All California locations
193 studies recruiting across 110 cities.
Los Angeles
92 studies recruiting.
San Francisco
29 studies recruiting.
Orange
23 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Colorectal Cancer Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections